Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Recruitment strategies for predominantly low-income, multi-racial/ethnic children and parents to 3-year community-based intervention trials: Childhood Obesity Prevention and Treatment Research (COPTR) Consortium.

Cui Z, Truesdale KP, Robinson TN, Pemberton V, French SA, Escarfuller J, Casey TL, Hotop AM, Matheson D, Pratt CA, Lotas LJ, Po'e E, Andrisin S, Ward DS.

Trials. 2019 May 28;20(1):296. doi: 10.1186/s13063-019-3418-0.

2.

Multicomponent Obesity Prevention Intervention in Low-Income Preschoolers: Primary and Subgroup Analyses of the NET-Works Randomized Clinical Trial, 2012-2017.

French SA, Sherwood NE, Veblen-Mortenson S, Crain AL, JaKa MM, Mitchell NR, Hotop AM, Berge JM, Kunin Batson AS, Truesdale K, Stevens J, Pratt C, Esposito L.

Am J Public Health. 2018 Dec;108(12):1695-1706. doi: 10.2105/AJPH.2018.304696.

PMID:
30403521
3.

Experimental Porcine Toxoplasma gondii Infection as a Representative Model for Human Toxoplasmosis.

Nau J, Eller SK, Wenning J, Spekker-Bosker KH, Schroten H, Schwerk C, Hotop A, Groß U, Däubener W.

Mediators Inflamm. 2017;2017:3260289. doi: 10.1155/2017/3260289. Epub 2017 Aug 13.

4.

A Tool Kit to Enhance the Informed Consent Process for Community-Engaged Pediatric Research.

Heerman WJ, White RO, Hotop A, Omlung K, Armstrong S, Mathieu I, Sherwood NE, Barkin SL.

IRB. 2016 Sep-Oct;38(5):8-14. No abstract available.

5.

Genotyping of samples from German patients with ocular, cerebral and systemic toxoplasmosis reveals a predominance of Toxoplasma gondii type II.

Herrmann DC, Maksimov P, Hotop A, Groß U, Däubener W, Liesenfeld O, Pleyer U, Conraths FJ, Schares G.

Int J Med Microbiol. 2014 Oct;304(7):911-6. doi: 10.1016/j.ijmm.2014.06.008. Epub 2014 Jun 27.

PMID:
25037927
6.

Humoral immune responses in chickens and turkeys after infection with Toxoplasma gondii by using recombinant antigens.

Hotop A, Buschtöns S, Bangoura B, Zöller B, Koethe M, Spekker-Bosker K, Hotop SK, Tenter AM, Däubener W, Straubinger RK, Groß U.

Parasitol Res. 2014 Apr;113(4):1473-80. doi: 10.1007/s00436-014-3788-x. Epub 2014 Feb 15.

PMID:
24532010
7.

Peptide microarray analysis of in silico-predicted epitopes for serological diagnosis of Toxoplasma gondii infection in humans.

Maksimov P, Zerweck J, Maksimov A, Hotop A, Gross U, Pleyer U, Spekker K, Däubener W, Werdermann S, Niederstrasser O, Petri E, Mertens M, Ulrich RG, Conraths FJ, Schares G.

Clin Vaccine Immunol. 2012 Jun;19(6):865-74. doi: 10.1128/CVI.00119-12. Epub 2012 Apr 11.

8.

Analysis of clonal type-specific antibody reactions in Toxoplasma gondii seropositive humans from Germany by peptide-microarray.

Maksimov P, Zerweck J, Maksimov A, Hotop A, Gross U, Spekker K, Däubener W, Werdermann S, Niederstrasser O, Petri E, Mertens M, Ulrich RG, Conraths FJ, Schares G.

PLoS One. 2012;7(3):e34212. doi: 10.1371/journal.pone.0034212. Epub 2012 Mar 28.

9.

Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy.

Hotop A, Hlobil H, Gross U.

Clin Infect Dis. 2012 Jun;54(11):1545-52. doi: 10.1093/cid/cis234. Epub 2012 Mar 29.

PMID:
22460980
10.

Maintenance-tailored therapy vs. standard behavior therapy for 30-month maintenance of weight loss.

Levy RL, Jeffery RW, Langer SL, Graham DJ, Welsh EM, Flood AP, Jaeb MA, Laqua PS, Finch EA, Hotop AM, Yatsuya H.

Prev Med. 2010 Dec;51(6):457-9. doi: 10.1016/j.ypmed.2010.09.010. Epub 2010 Sep 24.

11.

The drop it at last study: six-month results of a phone-based weight loss trial.

Sherwood NE, Jeffery RW, Welsh EM, Vanwormer J, Hotop AM.

Am J Health Promot. 2010 Jul-Aug;24(6):378-83. doi: 10.4278/ajhp.080826-QUAN-161.

12.

Is frequent self-weighing associated with poorer body satisfaction? Findings from a phone-based weight loss trial.

Welsh EM, Sherwood NE, VanWormer JJ, Hotop AM, Jeffery RW.

J Nutr Educ Behav. 2009 Nov-Dec;41(6):425-8. doi: 10.1016/j.jneb.2009.04.006.

13.

A comparison of maintenance-tailored therapy (MTT) and standard behavior therapy (SBT) for the treatment of obesity.

Jeffery RW, Levy RL, Langer SL, Welsh EM, Flood AP, Jaeb MA, Laqua PS, Hotop AM, Finch EA.

Prev Med. 2009 Nov;49(5):384-9. doi: 10.1016/j.ypmed.2009.08.004. Epub 2009 Aug 18.

14.

Energy density and weight change in a long-term weight-loss trial.

Flood A, Mitchell N, Jaeb M, Finch EA, Laqua PS, Welsh EM, Hotop A, Langer SL, Levy RL, Jeffery RW.

Int J Behav Nutr Phys Act. 2009 Aug 14;6:57. doi: 10.1186/1479-5868-6-57.

15.

Mood, Weight, and Physical Activity Among Obese Individuals Enrolled In a Long-term Weight-loss Program: Trajectories and Associations with Gender.

Langer SL, Flood AP, Welsh EM, Levy RL, Jaeb MA, Laqua PS, Hotop AM, Mitchell NR, Jeffery RW.

Internet J Ment Health. 2009;6(1). pii: 45.

16.

Modified calcium accumulation after controlled cortical impact under cyclosporin A treatment: a 45Ca autoradiographic study.

Mirzayan MJ, Klinge PM, Ude S, Hotop A, Samii M, Brinker T, Korkmaz Z, Meyer GJ, Knapp WH, Samii A.

Neurol Res. 2008 Jun;30(5):476-9.

PMID:
18953738

Supplemental Content

Support Center